Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
21 Jun 2024
Historique:
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 21 6 2024
Statut: ppublish

Résumé

Neuroblastoma is a childhood developmental cancer; however, its embryonic origins remain poorly understood. Moreover, in-depth studies of early tumor-driving events are limited because of the lack of appropriate models. Herein, we analyzed RNA sequencing data obtained from human neuroblastoma samples and found that loss of expression of trunk neural crest-enriched gene

Identifiants

pubmed: 38905335
doi: 10.1126/sciadv.ado1583
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado1583

Auteurs

Elina Fredlund (E)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Stina Andersson (S)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Elien Hilgert (E)

Center for Medical Genetics, Ghent University, Ghent, Belgium.

Ezequiel Monferrer (E)

Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Low Prevalence Tumors, Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Guadalupe Álvarez-Hernán (G)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Sinan Karakaya (S)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Siebe Loontiens (S)

Center for Medical Genetics, Ghent University, Ghent, Belgium.

Jan Willem Bek (JW)

Center for Medical Genetics, Ghent University, Ghent, Belgium.

Tomas Gregor (T)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Estelle Lecomte (E)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Emma Magnusson (E)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Enrika Miltenyte (E)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Marie Cabirol (M)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Michail Kyknas (M)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Niklas Engström (N)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Marie Arsenian Henriksson (MA)

Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum B7, Karolinska Institute, Stockholm, Sweden.
Department of Laboratory Medicine, Lund University, Lund, Sweden.

Emma Hammarlund (E)

Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.
Department of Laboratory Medicine, Lund University, Lund, Sweden.

Jared S Rosenblum (JS)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD 20892, USA.

Rosa Noguera (R)

Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Low Prevalence Tumors, Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Frank Speleman (F)

Center for Medical Genetics, Ghent University, Ghent, Belgium.

Johan van Nes (J)

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Sofie Mohlin (S)

Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University Cancer Center, Lund University, Lund, Sweden.
Lund Stem Cell Center, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH